Criticism - e-flux
Multiple lentigines, myxoid tumours and endocrine overactivity; four cases of Carney's complex
Black History Collections | Institute of Historical Research
Platelet Proteomes, Pathways, and Phenotypes as Informants of Vascular Wellness and Disease | Arteriosclerosis, Thrombosis, and Vascular Biology
Frontiers | Process Evaluation of Project FFAB (Fun Fast Activity Blasts): A Multi-Activity School-Based High-Intensity Interval Training Intervention
Shop
Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples | Nature Communications
Fra Angelico - MetPublications - The Metropolitan Museum of Art
Phenotype-Guided Comparative Genomics Identifies the Complete Transport Pathway of the Antimicrobial Lasso Peptide Ubonodin in Burkholderia | ACS Chemical Biology
President's and Dean's list announced for spring 2021 | Georgia Highlands College
Tapestry in the Renaissance: Art and Magnificence - MetPublications - The Metropolitan Museum of Art
Painting and Illumination in Early Renaissance Florence, 1300–1450 - MetPublications - The Metropolitan Museum of Art
The evolutionary history of 2,658 cancers | Nature
An Hour
Medicina | Free Full-Text | Conservative Trio-Therapy for Varus Knee Osteoarthritis: A Prospective Case-Study
IJMS | Free Full-Text | Inflammation-Induced Tumorigenesis and Metastasis
1,700+ Nebraska health care workers signed this letter asking for your help | Nebraska Medicine Omaha, NE
They Were Loved: Honouring Canada's COVID-19 victims - Macleans.ca
Our Supporters | Donations at the New York Philharmonic
The repertoire of mutational signatures in human cancer | Nature
Integrating climate adaptation and biodiversity conservation in the global ocean | Science Advances
University of Alabama Honors List Fall 2018
O/7366 Leading Signalman Campbell Howard Buchanan Navy Cross (US), MiD, RNZNVR – RNZN Communicators Association
Pre-Assessment Measures
O/7366 Leading Signalman Campbell Howard Buchanan Navy Cross (US), MiD, RNZNVR – RNZN Communicators Association
![Discovery of the Potent and Selective M1 PAM-Agonist N-[(3R,4S)-3-Hydroxytetrahydro-2H-pyran-4-yl]-5-methyl-4-[4-(1,3-thiazol-4-yl)benzyl]pyridine-2-carboxamide (PF-06767832): Evaluation of Efficacy and Cholinergic Side Effects | Journal of Medicinal ...](https://pubs.acs.org/cms/10.1021/acs.jmedchem.6b00544/asset/images/large/jm-2016-005448_0019.jpeg "Discovery of the Potent and Selective M1 PAM-Agonist N-[(3R,4S)-3-Hydroxytetrahydro-2H-pyran-4-yl]-5-methyl-4-[4-(1,3-thiazol-4-yl)benzyl]pyridine-2-carboxamide (PF-06767832): Evaluation of Efficacy and Cholinergic Side Effects | Journal of Medicinal ...")